These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12646398)

  • 1. In vivo and in vitro pharmacological studies of a new hypotensive compound (QF0301B) in rat: comparison with prazosin, a known alpha1-adrenoceptor antagonist.
    Orallo F; Garcia-Ferreiro T; Enguix MJ; Tristan H; Masaguer C; Ravina E; Cadavid I; Loza MI
    Vascul Pharmacol; 2003 Feb; 40(2):97-108. PubMed ID: 12646398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of N-methyl-actinodaphnine, a new vascular alpha-adrenoceptor antagonist, isolated from Illigera luzonensis.
    Guh JH; Ko FN; Yu SM; Wu YC; Teng CM
    Eur J Pharmacol; 1995 Jun; 279(1):33-41. PubMed ID: 7556380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
    Eltze M; Boer R
    Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the in vivo and in vitro cardiovascular effects of four new analogues of ketanserin: implication of 5-HT2A and alpha1 adrenergic antagonism in their hypotensive effect.
    Orallo F; Tristan H; Garcia-Ferreiro T; De Francisco S; Masaguer C; Raviña E; Calleja JM; Cadavid I; Loza MI
    Biol Pharm Bull; 2000 May; 23(5):558-65. PubMed ID: 10823664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-adrenoceptor antagonist activity of novel pyrimidine derivatives (SHI437 and IK29) in rabbit aorta and trigone of the bladder.
    Azuma H; Sugimoto-Tokushima M; Tanaka K; Ikenoue Y; Ito S; Ishikawa M
    Br J Pharmacol; 1989 Apr; 96(4):1000-6. PubMed ID: 2568139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that alpha(1B)-adrenoceptors are involved in noradrenaline-induced contractions of rat tail artery.
    Jähnichen S; Eltze M; Pertz HH
    Eur J Pharmacol; 2004 Mar; 488(1-3):157-67. PubMed ID: 15044047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Aono J; Nabata H; Ishizuka N; Sakai K
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
    Yen MH; Sheu JR; Peng IH; Lee YM; Chern JW
    J Pharm Pharmacol; 1996 Jan; 48(1):90-5. PubMed ID: 8722503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues.
    Ohira A; Wada Y; Fujii M; Nakamura M; Kasuya Y; Hamada Y; Shigenobu K
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):61-71. PubMed ID: 2869737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I; Coates J; Drew GM; Sullivan AT
    Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of alpha1-adrenoceptor-mediated contraction in the mouse thoracic aorta.
    Yamamoto Y; Koike K
    Eur J Pharmacol; 2001 Jul; 424(2):131-40. PubMed ID: 11476759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterisation of alpha(1)-adrenoceptors in denervated rat vas deferens.
    Campos M; de Lucena Morais P; Pupo AS
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):72-8. PubMed ID: 12845422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of ocoteine, isolated from Cassytha filiformis, as an alpha 1-adrenoceptor antagonist in rat thoracic aorta.
    Chang CW; Ko FN; Su MJ; Wu YC; Teng CM
    Jpn J Pharmacol; 1997 Mar; 73(3):207-14. PubMed ID: 9127815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.